Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

被引：4

作者：

Khatir, Wassila ^{[1
,2
]}

Humbert, Olivier ^{[3
]}

Benzaquen, Jonathan ^{[2
,4
]}

Bontoux, Christophe ^{[1
,2
]}

Neels, Jaap ^{[5
]}

Berland, Lea ^{[1
,6
]}

Rivera, Fabian Andres Gallardo ^{[7
]}

Allegra, Maryline ^{[8
]}

Salah, Myriam ^{[8
]}

Tanga, Virginie ^{[8
]}

Bordone, Olivier ^{[8
]}

Fayada, Julien ^{[8
]}

Lespinet-Fabre, Virginie ^{[1
]}

Bohly, Doriane ^{[8
]}

Long-Mira, Elodie ^{[1
,2
]}

Lassalle, Sandra ^{[1
,2
]}

Vouret, Valerie ^{[2
]}

Brest, Patrick ^{[2
]}

Mograbi, Baharia ^{[2
]}

Maniel, Charlotte ^{[4
]}

Otto, Josiane ^{[9
]}

Boutros, Jacques ^{[4
]}

Heeke, Simon

Hofman, Veronique ^{[1
,2
,8
]}

Marquette, Charles-Hugo ^{[2
,4
]}

Hofman, Paul ^{[1
,2
,8
]}

Ilie, Marius ^{[1
,2
,8
,10
]}

机构：

[1] Univ Cote DAzur, CHU Nice, Lab Clin & Expt Pathol, FHU OncoAge, Nice, France

[2] Univ Cote DAzur, Ctr Antoine Lacassagne, Inst Res Canc & Aging IRCAN, CNRS,INSERM,Team 4, Nice, France

[3] Univ Cote DAzur, Ctr Antoine Lacassagne, Dept Nucl Med, Nice, France

[4] Univ Cote DAzur, CHU Nice, Dept Pulm Med & Thorac Oncol, FHU OncoAge, Nice, France

[5] Univ Cote DAzur, Ctr Mediterraneen Med Mol C3M, INSERM, Team Metab Challenges Immune Cells Obes Diabet &, Nice, France

[6] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA

[7] Bellvitge Inst Biomed Res IDIBELL, Biobank, Barcelona, Spain

[8] Univ Cote DAzur, CHU Nice, FHU OncoAge, Biobank Cote DAzur, BB 0033 00025, Nice, France

[9] Univ Cote DAzur, Ctr Antoine Lacassagne, Dept Med Oncol, Nice, France

[10] UT MD Anderson Canc Ctr, Dept Thorac H&N Med Oncol, Houston, TX 77058 USA

来源：

CLINICAL AND TRANSLATIONAL MEDICINE | 2022年 / 12卷 / 08期

关键词：

D O I：

10.1002/ctm2.1018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：6

共 50 条

[1] Identification of a predictive circulating immunological signature of response to immune checkpoint inhibitors in non-small cell lung cancer
Khatir, Wassila
Humbert, Olivier
Neels, Jaap
Berland, Lea
Benzaquen, Jonathan
Rivera, Fabian Andres Gallardo
Allegra, Maryline
Salah, Myriam
Tanga, Virginie
Bordone, Olivier
Fayada, Julien
Lespinet-Fabre, Virginie
Long-Mira, Elodie
Lassalle, Sandra
Brest, Patrick
Vouret, Valerie
Maniel, Charlotte
Boutros, Jacques
Heeke, Simon
Hofman, Veronique
Marquette, Charles-Hugo
Hofman, Paul
Ilie, Marius
[J]. CANCER RESEARCH, 2022, 82 (12)
[2] Identification of Predictive Biomarkers for Immunotherapy with Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Kubo, S.
Kobayashi, N.
Muraoka, T.
Kanaoka, H.
Somekawa, K.
Hirata, M.
Kamimaki, C.
Ikeda, S.
Hirama, N.
Ushio, R.
Manabe, S.
Yamamoto, M.
Kudo, M.
Kaneko, T.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[3] Identification of immune-related gene signature for non-small cell lung cancer patients with immune checkpoint inhibitors
Wang, Li
Han, Chaonan
Cai, Chenlei
Wu, Jing
Chen, Jianing
Su, Chunxia
[J]. HELIYON, 2024, 10 (05)
[4] Immune checkpoint inhibitors in advanced non-small cell lung cancer
Fabre, Elizabeth
Pecuchet, Nicola
Cadranel, Jacques
[J]. BULLETIN DU CANCER, 2016, 103 : S138 - S143
[5] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
Assi, Hazem I.
Kamphorst, Alice O.
Moukalled, Nour M.
Ramalingam, Suresh S.
[J]. CANCER, 2018, 124 (02) : 248 - 261
[6] Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Huang, Yiqing
Zhao, Joseph J.
Soon, Yu Yang
Kee, Adrian
Tay, Sen Hee
Aminkeng, Folefac
Ang, Yvonne
Wong, Alvin S. C.
Bharwani, Lavina D.
Goh, Boon Cher
Soo, Ross A.
[J]. CANCERS, 2023, 15 (10)
[7] Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Ushio, Ryota
Murakami, Shuji
Saito, Haruhiro
[J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
[8] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
Lin, Gen
Wang, Zhijie
Chu, Qian
Hu, Yi
Huang, Dingzhi
Wang, Jun
Yang, Fan
Zhong, Wenzhao
Zhou, Chengzhi
Zhu, Bo
Ai, Xinghao
Cao, Baoshan
Cao, Yabing
Chen, Mingqiu
Chen, Xiaohui
Chu, Tianqing
Duan, Jianchun
Fan, Yun
Fang, Yong
Feng, Shuitu
Feng, Weineng
Guo, Hui
Han, Chengbo
He, Yong
Hong, Shaodong
Hu, Jie
Huang, Meijuan
Huang, Yan
Jiang, Da
Jiang, Kan
Jiang, Richeng
Jin, Bo
Jin, Shi
Li, Jisheng
Li, Min
Li, Ziming
Li, Chao
Lin, Jie
Liu, Anwen
Liu, Si-Yang Maggie
Yutao, Liu
Liu, Zhefeng
Liu, Zhe
Liu, Zhenhua
Liu, Zhentian
Liu, Zhigang
Lu, Yuping
Lv, Tangfeng
Ma, Zhiyong
Miao, Qian
[J]. THORACIC CANCER, 2024, 15 (05) : 419 - 426
[9] The role of immune checkpoint inhibitors in advanced non-small cell lung cancer
Pistamaltzian, Nikolaos F.
Georgoulias, Vassilis
Kotsakis, Athanasios
[J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 435 - 447
[10] Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol
Sannicolo, Sarah
Levra, Matteo Giaj
Le Gouellec, Audrey
Aspord, Caroline
Boccard, Julien
Chaperot, Laurence
Toussaint, Bertrand
Moro-sibilot, Denis
Hannani, Dalil
Toffart, Anne-Claire
[J]. RESPIRATORY MEDICINE AND RESEARCH, 2021, 80

← 1 2 3 4 5 →